Evidence map›Paper›PMID 18578886›Full record

ArticleBMC infectious diseases2008

Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells.

Haa-Yung Lee, Tamotsu Takeshita, Jun Shimada, Arsen Akopyan, Jeong-Im Woo, Huiqi Pan, Sung K Moon, Ali Andalibi, Rae-Kil Park, Sung-Ho Kang and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 56 citations in OpenAlex.

  1. Effects ofMetabolites · 2025
    Article
  2. Article
  3. Article
  4. Micro RNAs and Circular RNAs in Different Forms of Otitis Media.International journal of molecular sciences · 2023
    Review
  5. Innate Immunity in the Middle Ear Mucosa.Frontiers in cellular and infection microbiology · 2021
    Review
  6. Review
  7. Article
  8. Nontypeable Haemophilus influenzae lysates increase heterogeneous nuclear ribonucleoprotein secretion and exosome release in human middle-ear epithelial cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  9. Article
  10. A proteomic characterization of NTHi lysates.International journal of pediatric otorhinolaryngology · 2016
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Role of innate immunity in the pathogenesis of otitis media.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2014
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Haa-Yung LeeThe Gonda Department of Cell and Molecular Biology, House Ear Institute, Los Angeles, CA, USA. hlee@hei.org
Tamotsu Takeshita
Jun Shimada
Arsen Akopyan
Jeong-Im Woo
Huiqi Pan
Sung K Moon
Ali Andalibi
Rae-Kil Park
Sung-Ho Kang
Shin-Seok Kang
Robert Gellibolian
David J Lim
House Clinic · USKonkuk University · KRUniversity of Southern California · US

Funding

Innate Immunity in Otitis Media PathogenesisR01DC005025 · NIDCD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIM, DAVID J. · 2001 to 2013
$4.1M
Imaging CoreP30DC006276 · NIDCD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EISENBERG, LAURIE S · 2003 to 2016
$3.9M
NIDCD NIH HHS P30 DC006276NIDCD NIH HHS P30DC006276NIDCD NIH HHS R01 DC005025NIDCD NIH HHS R01 DC05025-04
6 · The paper itself

Abstract

backgroundAll mucosal epithelia, including those of the tubotympanium, are secreting a variety of antimicrobial innate immune molecules (AIIMs). In our previous study, we showed the bactericidal/bacteriostatic functions of AIIMs against various otitis media pathogens. Among the AIIMs, human beta-defensin 2 is the most potent molecule and is inducible by exposure to inflammatory stimuli such as bacterial components or proinflammatory cytokines. Even though the beta-defensin 2 is an important AIIM, the induction mechanism of this molecule has not been clearly established. We believe that this report is the first attempt to elucidate NTHi induced beta-defensin expression in airway mucosa, which includes the middle ear.

methodsMonoclonal antibody blocking method was employed in monitoring the TLR-dependent NTHi response. Two gene knock down methods - dominant negative (DN) plasmid and small interfering RNA (siRNA) - were employed to detect and confirm the involvement of several key genes in the signaling cascade resulting from the NTHi stimulated beta-defensin 2 expression in human middle ear epithelial cell (HMEEC-1). The student's t-test was used for the statistical analysis of the data.

resultsThe experimental results showed that the major NTHi-specific receptor in HMEEC-1 is the Toll-like receptor 2 (TLR2). Furthermore, recognition of NTHi component(s)/ligand(s) by TLR2, activated the Toll/IL-1 receptor (TIR)-MyD88-IRAK1-TRAF6-MKK3/6-p38 MAPK signal transduction pathway, ultimately leading to the induction of beta-defensin 2.

conclusionThis study found that the induction of beta-defensin 2 is highest in whole cell lysate (WCL) preparations of NTHi, suggesting that the ligand(s) responsible for this up-regulation may be soluble macromolecule(s). We also found that this induction takes place through the TLR2 dependent MyD88-IRAK1-TRAF6-p38 MAPK pathway, with the primary response occurring within the first hour of stimulation. In combination with our previous studies showing that IL-1alpha-induced beta-defensin 2 expression takes place through a MyD88-independent Raf-MEK1/2-ERK MAPK pathway, we found that both signaling cascades act synergistically to up-regulate beta-defensin 2 levels. We propose that this confers an essential evolutionary advantage to the cells in coping with infections and may serve to amplify the innate immune response through paracrine signaling.

Indexed as

Animalsbeta-DefensinsCell LineEar, MiddleEpithelial CellsHaemophilus influenzaeHumansInterleukin-1 Receptor-Associated KinasesMaleMiceMice, Inbred C57BLMyeloid Differentiation Factor 88p38 Mitogen-Activated Protein KinasesSignal TransductionTNF Receptor-Associated Factor 6Toll-Like Receptor 2beta-DefensinsDEFB4A protein, humanInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanMyeloid Differentiation Factor 88p38 Mitogen-Activated Protein KinasesTNF Receptor-Associated Factor 6Toll-Like Receptor 2

Identifiers

PMID18578886
PMCPMC2447838
OpenAlexW2053046804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.